The data indicates a 25.72% single-session drawdown on the 2x leveraged ETF tracking SK Hynix. Within hours, a prominent investor declared he had "exhausted all ammunition" to buy the dip. This is not a trade report. It is a specimen of conviction colliding with mathematics. The market is sideways, and chop is for positioning. But this positioning reveals a fundamental misunderstanding of the instrument being traded.
Context
Dan Bin is a well-known Chinese equity investor, founder of Dongfang Harbor, with a public track record of bullish calls on tech and AI. His recent focus is SK Hynix, the South Korean memory semiconductor giant. SK Hynix is the primary supplier of High Bandwidth Memory (HBM) for NVIDIA’s AI accelerators — a fact that has driven the stock to multi-year highs. The AI narrative is seductive: demand for HBM is insatiable, NVIDIA’s dominance is assumed, and SK Hynix’s technological lead in advanced packaging (MR-MUF) seems unassailable. In this environment, a sharp correction becomes a buying opportunity. On July 2025, after a 25.72% drop in the 2x leveraged ETF (ticker: 2SKH), Dan Bin tweeted that he had used all his remaining cash to add to the position. The post was shared widely as a signal of conviction.
But the product he used is not equity. It is a daily rebalanced leveraged exchange-traded note. Every emotion in that tweet is filtered through a structural flaw that, in the absence of data, opinion is just noise.
Core: Systematic Teardown
Let us dissect the three primary risks embedded in this trade. Each is a "bug" in the investment thesis.
1. Volatility Decay (the silent killer)
A 2x leveraged ETF seeks to deliver twice the daily return of the underlying asset. It does not deliver twice the longer-term return. Daily rebalancing introduces a compounding drag known as volatility decay. Consider three scenarios for SK Hynix stock over 20 trading days:
- Scenario A: Up 1% every day -> stock returns +22.0% -> 2x ETF returns +48.6% (close to 2x).
- Scenario B: Volatile with no net change: up 5% then down 4.76% repeatedly. Stock returns 0% after 20 days. 2x ETF returns ?????????? Calculate: each two-day cycle: up 10% then down 9.52% = (1.10 * 0.9048) = 0.9953 -> loss of 0.47% per cycle. After 10 cycles, ETF is down approximately 4.6% even though the stock is flat. That is volatility decay.
- Scenario C: Single 25% drop then recovery. Stock drops 25% one day, then rises 33.3% the next to recover. Stock returns 0%. 2x ETF: day1 drop 50% to 50, day2 rise 66.6% to 83.33 -> net loss 16.67%.
The product Dan Bin bought suffers from severe decay in choppy markets. The current market — sideways and volatile — is the worst environment for leveraged ETFs. The trade is a bet not only on direction but also on low volatility. He is implicitly short volatility. That is a dangerous position for a long-term conviction investor.
2. Concentration and Single-Point-of-Failure Risk
SK Hynix’s HBM business is tied to NVIDIA’s GPU roadmap. If NVIDIA diversifies to Samsung (already happening), or if AI capital expenditure growth slows, or if the HBM4 transition introduces manufacturing challenges, SK Hynix’s revenue growth could stall. The thesis holds that HBM is a structural upgrade to DRAM pricing power. However, the customer has leverage. NVIDIA can — and will — pressure margins. A 10% price cut on HBM3E would directly impact SK Hynix’s profitability. The 2x ETF amplifies that single-stock risk. Holding a leveraged position in a stock that is itself a leveraged play on one customer is stacking leverage on leverage. It magnifies the risk of a permanent capital loss.
3. Geopolitical Blind Spot
The analysis by semiconductor industry experts — which Dan Bin likely does not read — reveals a glaring omission: export controls. The US has already targeted AI chips. HBM is the bottleneck. Any further escalation of the semiconductor technology war between the US and China could restrict SK Hynix’s ability to sell to certain markets or force redesigns. The Korean government is under pressure to align with the US. If SK Hynix is forced to cut off supply to China (even indirectly), its revenue from traditional DRAM — which still constitutes a large portion of its business — would suffer. The investor’s tweet made no mention of this. In the absence of data, opinion is just noise.
4. Contradiction in Risk Management
The same investor who warned followers to “use leverage cautiously” has now deployed his entire remaining cash into a 2x leveraged instrument. This is not a contradiction; it is a failure of process. During my 2017 ICO audit, I flagged a token project where the founder swore by “risk controls” while personally holding 40% of the supply in an unvested wallet. The behavior is the same: stated principles diverge from actual actions. The data does not care about your feelings.
Contrarian: What the Bulls Got Right
To be fair, the bullish case has merit. SK Hynix’s MR-MUF packaging technology is genuinely superior for HBM stacking. The company has a multi-quarter lead in HBM3E qualification with NVIDIA. The total addressable market for HBM is expanding as AI moves from training to inference. Inference still requires high bandwidth, albeit with potentially lower density per chip. If SK Hynix maintains its 50% market share and HBM remains a high-margin product, the earnings trajectory is strongly upward. The leveraged ETF, if held through a smooth uptrend with low volatility, could produce outsized returns. The 400% gain over the past year cited in the article is a result of such a trend — low intraday volatility combined with a strong directional move. The investor’s belief that demand is structurally higher is not wrong. The error is in the instrument selection, not the thesis.
Takeaway
The next time you see a prominent voice announce a leveraged dip-buy with “all ammunition”, pause and run the numbers. Simulate a sideways week. Calculate the decay. Consider the single-stock risk. Ask: In the absence of data, is this conviction or noise? The data indicates that leveraged ETFs are designed for short-term tactical trades, not for expressing long-term conviction. Dan Bin’s bet is a spectacular one, but it is not a safe one. The market’s chop will eventually test the arithmetic. And arithmetic has no mercy.
